ML278
ML278 is an efficient, low toxicity, and plasma stable SR-BI (IC50 = 6 nM) lipid uptake inhibitor. ML278 enhances HDL binding while inhibiting SR-BI mediated lipid uptake. ML278 can be used for research on metabolic conditions[1].
Product Specifications
CAS Number
1604821-43-3
UNSPSC
12352005
Target
Scavenger Receptor Class B type I (SR-BI)
Related Pathways
Immunology/Inflammation
Field of Research
Metabolic Disease
Smiles
O=C(NC1=NC(C2=CC3=C(N(C(COC)=O)CC3)C=C2)=CS1)C4=CC(OC)=CC(OC)=C4
Molecular Formula
C23H23N3O5S
Molecular Weight
453.51
References & Citations
[1]Dockendorff C, et al. Indolinyl-Thiazole Based Inhibitors of Scavenger Receptor-BI (SR-BI) -Mediated Lipid Transport. ACS Med Chem Lett. 2015 Feb 2;6 (4) :375-380.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A135262 100 µL
Talquetamab Biosimilar (Monoclonal, Ig (G4-kappa_G4-lambda) )
Sign In for Pricing
View Details 036034-ML405 100 µL
GHSR, CT (GHSR, Growth hormone secretagogue receptor type 1, GH-releasing peptide receptor, Ghrelin receptor) (MaxLight 405) discontinued
Sign In for Pricing
View Details